PERIOPERATIVE NURSES FACE a challenge in using opioids to treat pain postoperatively. There is a delicate balance in the achievement of adequate pain control while avoiding adverse effects, such as opioid-induced sedation. 1 Opioidinduced sedation ranges from drowsiness to loss of consciousness and respiratory arrest. If the nurse does not recognize the warning signs of impending opioid-induced sedation, respiratory depression may occur. ''A number of criteria have been used to define respiratory depression including ventilatory frequency, percutaneous oxygen saturation, arterial blood gas analysis, and the need to administer respiratory stimulants'' 2 (p. 216) . In 2004, Cashman and Dolin 2 identified ventilatory frequency as the most widely used criterion, with a respiratory rate of less than ten breaths per minute as the most common cut-off value. Respiratory depression because of opioidinduced sedation is estimated to occur in 0.2% to 1% of all patients receiving opioids, 2 potentially leading to increased lengths of stay and overall costs. 3 In 2012, the Joint Commission published a document to illustrate the number of sentinel events related to opioid administration between 2004 and 2011: incorrect doses (47%), inadequate monitoring (29%), and other factors including overdosage, adverse effects, and other medication interactions (11%). 4 In response to the Joint Commission 2001 Pain Management Standards, concern has been expressed regarding the potential for overaggressive efforts to reduce reported pain control to nil. 5 With concern about increasing opioid-related adverse events, there is growing interest in developing effective means to provide adequate pain control while minimizing adverse events.
Postanesthesia care unit (PACU) nurses have the role and responsibility to ensure tolerable pain levels of postsurgical patients before discharge from surgical recovery. In 2001, the American Society of PeriAnesthesia Nurses (ASPAN) attempted to address pain and comfort management by conducting a descriptive study of 220 perianesthesia nurses at multiple sites. Study findings illustrated variance of nursing practice regarding the frequency of assessments, thereby, leading to the development and publication of the ASPAN Pain and Comfort Clinical Guideline in 2003. 6, 7 To date, the only guideline addressing pain and comfort management for perianesthesia nursing is the 2003 Clinical Guideline. The initial assessment of pain should include the patients' self-reports, sedation levels, nonverbal behaviors, and vital signs. After providing the recommended interventions, which may include opioid therapy, ASPAN suggests that nurses should monitor the patients for respiratory function, level of consciousness, and hemodynamic stability. Determining the patients' levels of pain should be accomplished by asking the patients to verbalize effectiveness of the intervention(s). 6 However, the guideline does not recommend the use of a standard sedation scale, nor does it provide guidance for actions to be taken for controlling pain if the patient becomes sedated during the course of opioid administration.
Without a protocol or algorithm guiding how to manage patients' pain, nurses may find it difficult to manage pain appropriately and determine when opioids can be safely administered. Historically, nurses have incorporated subjective data to include clinical judgment, nonverbal behavior, and self-reported pain scores, along with vital signs, to determine if additional doses of opioids can be safely administered. 6 However, these approaches reflect increased variability and decreased reliability. Often, a physician's order for pain medication is prescribed in accordance with the patient reported pain level; however, the subjective report of pain does not correlate with the patient's sedation level. Patients may be able to report a pain score of 7 or higher, yet could be excessively sedated. If the nurse administered an opioid to the patient with no consideration of the patient's sedation level, the patient may be at high risk for developing advanced opioid-induced respiratory depression. 8 Sedation scales are used to assess sedation levels and provide nurses with a useful tool to make decisions about the timing of medication interventions and when to intervene based on patients' sedation levels. The Pasero Opioid Sedation Scale (POSS) is a tool developed to identify advancing sedation before it is compounded by continued opioid administration and results in clinically significant respiratory depression or apnea, thereby enhancing patient safety during pain management with opioid analgesics. The tool ( Figure 1 ) is designed to correlate a level of sedation with a specific intervention providing additional support in clinical decision making, and appropriate and timely escalation of care. The levels of sedation range from sleep, easy to arouse (S)/awake and alert (1)/slightly drowsy, easily aroused (2)/frequently drowsy, arousable, drifts off to sleep during conversation (3)/somnolent, with minimal or no response to verbal and physical stimulation (4). 9 The POSS indicates the nurse may administer opioids to a patient at sedation level S (sleep, easy to arouse) if it has been determined that the patient's respiratory status (rate, depth, regularity, and airway patency) is optimal. Patients assigned a sedation level of 1 or 2 may receive opioid administration; however, beginning at sedation level 3, the recommendation is that the nurse should provide nonopioid therapies to treat pain because the patient is becoming too sedated. Nonopioid therapies commonly used in the PACU may include acetaminophen or nonsteroidal anti-inflammatory drugs. A sedation level of 4 is indicative of somnolence, with minimal or no response to verbal and physical stimulation. This level is unacceptable and deems an escalation of care, to include stopping the opioid and consideration of administering naloxone. 9 The purpose of this article was to review sedation scales and monitoring practices, specifically, evaluating use of the POSS in the clinical setting. *Appropriate action is given in italics at each level of sedation. 1 If opioid analgesic orders or hospital protocol do not include the expectation that the opioid dose will be decreased if a patient is excessively sedated, such orders should be promptly obtained. 2 For example, the physician, nurse practitioner, advanced practice nurse, or physician assistant responsible for the pain management prescription. 3 For adults experiencing respiratory depression give intravenous naloxone very slowly while observing patient response ("titrate to effect"). If sedation and respiratory depression occurs during administration of transdermal fentanyl, remove the patch; if naloxone is necessary, treatment will be needed for a prolonged period, and the typical approach involves a naloxone infusion. Patient must be monitored closely for at least 24 hours after discontinuation of the transdermal fentanyl. 4 Hospital protocols should include the expectation that a nurse will administer naloxone to any patient suspected of having life-threatening opioid-induced sedation and respiratory depression. 
Findings

Implementation of the POSS
The search query yielded two articles designed to evaluate the safety and efficacy of the POSS in a clinical environment. Kobelt et al 8 conducted a quasi-experimental study (1) to measure the efficacy of the POSS with interventions in the PACU; (2) to increase PACU nurses' perceptions of their confidence in assessing sedation associated with opioid administration and in the quality of care provided; and (3) to facilitate communications during patient handoffs postoperatively regarding safe opioid administration. The POSS protocol was implemented across two PACUsgeneral and orthopaedic. Surveys were distributed among 67 nurses, 46 from postsurgical units and 21 from two PACUs. A 10-point Likert Scale was used to capture changes in perceptions associated with the implementation of the POSS protocol, 1-point as least favorable to 10-point as most favorable. A review of 842 medical records was used to evaluate the efficacy of the protocol, preimplementation and postimplementation. Study authors concluded an increased perception of quality care delivered related to opioid administration and communication of pain and sedation assessments during patient handoff. They also noted increased nurses' confidence regarding opioid administration, including the avoidance of oversedation. Implementation of the tool did not affect the length of stay in the PACU, increase notification to PACU providers (anesthesia or surgeons), amount of opioid medication administered, or patient reported pain level. The protocol raised awareness among patients and nursing staff. Study authors noted that an increased number of patients were able to report a pain level on discharge from the PACU and increased compliance among PACU nurses with the protocol, including associated interventions of opioid administration and evaluation for discharge. The overall findings support use of the POSS protocol in the PACU. 8 Quinlan-Colwell et al 10 sought to determine if using the POSS in a pediatric population was a safe and effective tool and to evaluate the quality and frequency of nursing documentation of sedation in pediatric patients before and after implementation of the POSS. A convenience sample was used to identify patients in the intervention group (n 5 27) and control group (n 5 25). The groups comprised pediatric patients admitted to the medical center for similar diagnoses; however, nurses caring for patients in the control group did not use a standardized assessment tool to monitor sedation levels. An anonymous voluntary survey recorded the perception of 43 nurses who administered opioids to patients in the intervention group for analgesia and used the POSS to assess sedation in the pediatric clinical unit or pediatric intensive care unit. The nurses found the tool to be safe and appropriate for the pediatric population. Implementation of the tool positively impacted the frequency of documentation of respiratory rate assessments before opioid administration. In addition, compliance regarding the documentation of pain score assessments increased by 16% after implementation. The tool standardized nursing assessments and corresponding documentation, thereby optimizing safe and effective pain management. 10 Smith et al 11 conducted an evidence-based practice project to standardize the way nurses assess for and monitor opioid-induced sedation in general care areas. A multidisciplinary team selected and implemented a hospital-wide policy requiring nurses' use of the POSS before and after opioid medication administration, to monitor sedation levels.
11 A four-point Likert Scale captured nursing knowledge of patient assessment, monitoring, and risk factors related to opioid administration, preimplementation and postimplementation. Implementation of the policy enhanced the nurses' ability to identify patients at risk for opioidinduced sedation, including clinical decision making regarding the administration of opioids. In addition, the nurses reported ease of understanding the tool when assessing for oversedation. Monthly audits for compliance prompted unitlevel education, resulting in 51% improved compliance with documentation of the initial POSS assessment over the 30-month timeframe.
11
Comparison of Commonly Used Sedation Scales
Nisbet and Mooney-Cotter 12 conducted a descriptive survey-based study to describe the validity and reliability of three sedation scales-the Inova Health System Acute Care Sedation Scale (ISS), the Richmond Agitation and Sedation Scale (RASS), and the POSS. Ninety-six nurses employed across medical and surgical units at a level I trauma hospital were randomly selected to complete a 25-question online questionnaire regarding demographics, scales, and knowledge of the relationship of advancing sedation to respiratory depression. A team of 15 content experts was selected to establish reliability and validity for the sedation scales. Selection was based solely on expertise. The expert panel successfully established content validity and reliability for the RASS and POSS. Validity was not established for the ISS. The nurses deemed the POSS significantly easier to use than the RASS or ISS. 12 The content experts determined ''use of the POSS more often resulted in the correct score and the correct actions chosen'' 12 (p. 161) .
Monitoring Practices
Willens et al 13 conducted a descriptive-based study to evaluate monitoring practices among the American Society for Pain Management Nursing (ASPMN) membership. Survey feedback from 102 participants indicated many institutions maintain recommended pain management practices, specifically integration of sedation assessments and respiratory parameters. 1 Ninety percent of the respondents reported using sedation scales, and 72% implemented an intervention based on the sedation score. The most commonly used sedation scale was the POSS, with implementation in 53% of hospitals surveyed. Other commonly used sedation scales were the RASS (42%), Aldrete Scale (39%), and Glasgow Coma Scale (37%). It is important to note that some hospitals reported use of more than one sedation scale. Jungquist et al 1 concluded that monitoring practices have improved since 2009. Specifically, noting an increase in the use of sedation scales and the subsequent prevention of adverse events. The POSS was the most commonly used sedation scale used in this study. 1 Willens et al 13 conducted a descriptive study to determine current opinions regarding the effectiveness, benefits, and deficiencies of existing practices used to monitor advancing sedation and respiratory depression in hospitalized patients receiving opioids for management of acute pain. An online survey was disseminated to ASPMN membership from 90 different institutions. The different monitoring methods covered in the survey were pulse oximetry monitoring, end tidal carbon dioxide (ETCO 2 ) monitoring, and sedation scales. Ten different sedation scales were used among the institutions, including the POSS. Among patients receiving intravenous (IV) or oral opioids, 37% were monitored with intermittent pulse oximetry, and 13% were monitored with continuous pulse oximetry. No institutions used ETCO 2 monitoring for patients receiving IV or oral opioids. Sixty-four percent of respondents reported assigning a number to sedation, 47% assigned an intervention to certain sedation scores, 60% reported that nurses regularly documented and appropriately used the sedation scales, and 42% reported that their use prevented adverse effects related to opioid administration. Only 21% of respondents reported using the POSS. Study authors concluded inconsistencies regarding clinical practices related to no standard of care for monitoring patients for opioid-induced respiratory depression. 13 
Discussion
There is limited research regarding the implementation of the POSS in a PACU and other clinical settings. Kobelt et al 8 and Quinlan-Colwell et al 10 used survey-based designs to assess perception, monitor compliance, and evaluate documentation and appropriateness of the tool in a PACU and a pediatric setting, respectively. Smith et al 11 conducted the sole evidence-based practice project to standardize monitoring of sedation in adult and pediatric patients receiving opioid analgesia. Nurses' ability to report improved identification of patients at risk for oversedation and to understand the POSS tool may be a result of the additional efforts to improve compliance and unit-level education.
Study limitations include design and sample size. All quasi-experimental and descriptive studies were retrospective and the subjects were part of a convenience sample and not randomized. 10 The retrospective design was quick and cheap and was not prone to loss of follow-up. However, recruitment by convenience sampling was not representative of the general population and prone to selection LITERATURE REVIEW: OPIOID-RELATED SEDATION bias. In addition, sources of error in chart reviews or from the use of electronic medical records, recall bias, or misclassification introduce potential biases.
The evidence-based practice project conducted by Smith et al 11 also used questionnaires' preimplementation and postimplementation to identify patient risk and establish monitoring parameters. The use of questionnaires introduces the same potential of recall bias or misclassification; however, the implementation process being conducted at an academic medical center lends to replication success.
Implications for Practice and Conclusions
The limited publications regarding implementation of a POSS in the PACU or other clinical setting reinforce the need for further research. Additional research or evidence-based practice projects should be conducted to evaluate the tool's applicability to the general population, improved outcomes, and financial impact. Overall, the literature supports the goal of the POSS, citing the potential for fewer opioid-related adverse events and increased confidence among nursing staff.
